Rolf Kiessling

29.5k citations
313 papers · 22.9k indexed · 4 hit papers · h-index 81

Impact in

  • Immunology top 0.02%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • Immune cells in cancer
    • Immune Response and Inflammation
  • Oncology top 0.1%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Immune Cell Function and Interaction 170
    • Immunotherapy and Immune Responses 116
    • T-cell and B-cell Immunology 86
    • Immune cells in cancer 31
    • Immune Response and Inflammation 24
    • Cancer Immunotherapy and Biomarkers 42
    • CAR-T cell therapy research 38

Rolf Kiessling

311 papers receiving 21.9k citations

Hit Papers

The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations 2000 · 615 citations
615197520261992200950010001.5k

Peers

Rolf Kiessling
Comparison fields: 5 of 151
  • Immunology 16.8k
  • Oncology 7.3k
  • Hematology 1.2k
  • Microbiology 612
  • Molecular Biology 5.5k
Replace Hans‐Georg Rammensee with:
Hans‐Georg Rammensee Germany
Pedro Romero Switzerland
Nina Bhardwaj United States
Michael J. Bevan United States
Frank O. Nestlé Switzerland
Mitchell Kronenberg United States
Gosse J. Adema Netherlands
Karolina Palucka United States
Stefan Stevanović Germany
Adrian Hayday United Kingdom
Rolf Kiessling relative to Hans‐Georg Rammensee Germany Hans‐Georg Rammensee's profile →
Citations per field
00.5×1.5×
Hans‐Georg Rammensee · 1×
Citations per year

Countries citing papers authored by Rolf Kiessling

Since Specialization
Citations

This map shows the geographic impact of Rolf Kiessling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Kiessling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Kiessling more than expected).

Fields of papers citing papers by Rolf Kiessling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Kiessling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Kiessling. The network helps show where Rolf Kiessling may publish in the future.

Co-authors

The 25 scholars most cited alongside Rolf Kiessling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rolf Kiessling Line = papers co-authored together Rolf Kiessling links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202036
2 201829
3 2016107
4 20143
5 2014225
6 2013110
7 2010329
8 201099
9 201023
10 2007189
11 20058
12 200557
13
Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes.
200328
14
Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer.
2002116
15 200263
16
Kommunikation und Region
20011
17
Konfessionalisierung und Region
19992
18 19977
19 19973
20 19804

About Rolf Kiessling

Rolf Kiessling is a scholar working on Immunology, Oncology, Immunology and Allergy, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 313 papers that have together received 22.9k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (170 papers), Immunotherapy and Immune Responses (116 papers), T-cell and B-cell Immunology (86 papers), Cancer Immunotherapy and Biomarkers (42 papers), CAR-T cell therapy research (38 papers), Immune cells in cancer (31 papers), Monoclonal and Polyclonal Antibodies Research (27 papers) and Immune Response and Inflammation (24 papers). The work is most often cited by research in Immunology (16.8k citations), Oncology (7.3k citations), Hematology (1.2k citations), Microbiology (612 citations) and Molecular Biology (5.5k citations). Rolf Kiessling has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Hans Wigzell, Eva Klein, Klas Kärre, Gerald E. Piontek, Hans Ljunggren, Isabel Poschke, Dimitrios Mougiakakos, Max Petersson, Giuseppe Masucci and Otto Haller. Their work appears in journals such as International Journal of Cancer, The Journal of Immunology, European Journal of Immunology, Cancer Immunology Immunotherapy and OncoImmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026